期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
检测卵巢癌细胞活性的XTT比色法的建立 被引量:10
1
作者 吴楠 崔恒 +3 位作者 钱和年 冯捷 傅天云 李小平 《北京医科大学学报》 CSCD 1998年第1期83-84,共2页
检测卵巢癌细胞活性的XTT比色法的建立吴楠△崔恒钱和年冯捷傅天云李小平(北京医科大学人民医院妇科肿瘤中心,北京100034)XTT(2,3bis(2methoxy4nitro5sulfophenyl)5... 检测卵巢癌细胞活性的XTT比色法的建立吴楠△崔恒钱和年冯捷傅天云李小平(北京医科大学人民医院妇科肿瘤中心,北京100034)XTT(2,3bis(2methoxy4nitro5sulfophenyl)5[(phenylamino)ca... 展开更多
关键词 卵巢肿瘤 卵巢癌细胞活性 XTT比色法
在线阅读 下载PDF
豹蛙抗瘤酶与人血清白蛋白融合蛋白的毕赤酵母高效表达与活性测定 被引量:4
2
作者 杨刚刚 马诚凯 +9 位作者 史世会 张全义 王泽 吕中原 王绪洋 许晓亚 崔晴晴 张继红 丁一 徐存拴 《生物技术通报》 CAS CSCD 北大核心 2015年第10期222-229,共8页
豹蛙抗瘤酶(Onconase,ONC),又称豹蛙酶,对多种肿瘤细胞和实体瘤具有显著杀伤作用,为得到高表达的ONC,利用HSA在毕赤酵母系统中的表达优势,将HSA和ONC融合进行毕赤酵母表达并分离纯化。设计融合基因HSA-(Gly4Ser1)3-ONC,简称HSA-ONC,构建... 豹蛙抗瘤酶(Onconase,ONC),又称豹蛙酶,对多种肿瘤细胞和实体瘤具有显著杀伤作用,为得到高表达的ONC,利用HSA在毕赤酵母系统中的表达优势,将HSA和ONC融合进行毕赤酵母表达并分离纯化。设计融合基因HSA-(Gly4Ser1)3-ONC,简称HSA-ONC,构建至3种表达载体p PIC9、p PIC9K、p PICZα-A并分别转染X-33、GS115和SMD1168 3种宿主菌,在摇瓶和10L规模优化表达条件和双水相偶联柱层析分离纯化目的蛋白并测定其生物学活性。结果显示,在1 L摇瓶规模下,p PICZα-A/X-33/HSA-ONC组合的表达量优于其他组合,且在p H7,温度23℃条件下诱导10 d,表达量达到最高(235 mg/L)。在10 L规模进行不同培养基条件的发酵,r HSA-ONC于p H 7的低盐基础盐培养基(Low salt basic salt mediu m,LS-BSM),甲醇浓度0.25%条件下诱导10 d,表达量达到最高(2.02 g/L)。经双水相萃取偶联DEAE离子交换层析可得到纯度≥95%、收率高于70%的r HSA-ONC。生物活性检测发现,r HSA-ONC在体外能抑制多种癌细胞增殖。r HSA-ONC的表达量较r ONC提高1倍(同等摩尔量情况下),同时在体外抑制多种癌细胞增殖。 展开更多
关键词 豹蛙抗瘤酶 人血清蛋白 毕赤酵母高效表达 双水相萃取 癌细胞活性
在线阅读 下载PDF
Copper complexes of anthrahydrazone bearing pyridyl side chain:Synthesis,crystal structure,anticancer activity,and DNA binding 被引量:1
3
作者 HUANG Yao WU Yingshu +5 位作者 BAO Zhichun HUANG Yue TANG Shangfeng LIU Ruixue LIU Yancheng LIANG Hong 《无机化学学报》 北大核心 2025年第1期213-224,共12页
To expand the study on the structures and biological activities of the anthracyclines anticancer drugs and reduce their toxic side effects,the new anthraquinone derivatives,9‑pyridylanthrahydrazone(9‑PAH)and 9,10‑bisp... To expand the study on the structures and biological activities of the anthracyclines anticancer drugs and reduce their toxic side effects,the new anthraquinone derivatives,9‑pyridylanthrahydrazone(9‑PAH)and 9,10‑bispyridylanthrahydrazone(9,10‑PAH)were designed and synthesized.Utilizing 9‑PAH and 9,10‑PAH as promising anticancer ligands,their respective copper complexes,namely[Cu(L1)Cl_(2)]Cl(1)and{[Cu_(4)(μ_(2)‑Cl)_(3)Cl_(4)(9,10‑PAH)_(2)(DMSO)_(2)]Cl_(2)}_(n)(2),were subsequently synthesized,where the new ligand L1 is formed by coupling two 9‑PAH ligands in the coordination reaction.The chemical and crystal structures of 1 and 2 were elucidated by IR,MS,elemental analysis,and single‑crystal X‑ray diffraction.Complex 1 forms a mononuclear structure.L1 coordinates with Cu through its three N atoms,together with two Cl atoms,to form a five‑coordinated square pyramidal geometry.Complex 2 constitutes a polymeric structure,wherein each structural unit centrosymmetrically encompasses two five‑coordinated binuclear copper complexes(Cu1,Cu2)of 9,10‑PAH,with similar square pyramidal geometry.A chlorine atom(Cl_(2)),located at the symmetry center,bridges Cu1 and Cu1A to connect the two binuclear copper structures.Meanwhile,the two five‑coordinated Cu2 atoms symmetrically bridge the adjacent structural units via one coordinated Cl atom,respectively,thus forming a 1D chain‑like polymeric structure.In vitro anticancer activity assessments revealed that 1 and 2 showed significant cytotoxicity even higher than cisplatin.Specifically,the IC_(50)values of 2 against HeLa‑229 and SK‑OV‑3 cancer cell lines were determined to be(5.92±0.32)μmol·L^(-1)and(6.48±0.39)μmol·L^(-1),respectively.2 could also block the proliferation of HeLa‑229 cells in S phase and significantly induce cell apoptosis.In addition,fluorescence quenching competition experiments suggested that 2 might interact with DNA by an intercalative binding mode,offering insights into its underlying anticancer mechanism.CCDC:2388918,1;2388919,2. 展开更多
关键词 anthrahydrazone metal complex crystal structure anticancer activity cell apoptosis
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部